We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASFY Launches Lincare to Improve Post-Laser Skincare
Read MoreHide Full Article
Key Takeaways
BASF launches Lincare, an active ingredient designed to accelerate post-laser skin recovery.
It exhibits 21% faster skin barrier recovery with 1% Lincare and up to twice the improvement in 14 days.
Lincare improved fine lines and wrinkles, boosting skin density by up to 16% after 56 days of treatment.
BASF SE (BASFY - Free Report) has launched Lincare, a naturally derived active ingredient designed to support post-laser skincare and promote rejuvenation, at in-cosmetics Asia 2026 in Bangkok, Thailand. The launch underscores the company's focus on supporting innovation in its beauty and personal care portfolio to address the growing need for skin-recovery mechanisms while helping enhance visible aesthetic results.
Derived from flaxseed hull oligosaccharides, Lincare supports skin recovery by soothing post-treatment skin, helping epidermal recovery, strengthening the skin barrier and enhancing visible rejuvenation benefits. Clinical testing demonstrated that a formulation containing 1% Lincare helped the skin barrier recover 21% faster following non-ablative fractional laser treatment, enabling recovery approximately 1.2 days earlier than placebo.
The ingredient also delivered up to twice the skin barrier improvement after 14 days. Additionally, it demonstrated improvements in forehead fine lines, crow's feet and nasolabial folds, along with up to 16% higher skin density after 56 days.
Alongside Lincare, BASFY is showcasing several innovations under its "Beyond Beauty: Future Unlocked" theme. These include Tinosorb A2B for advanced sun care, Emulgade Verde PE for active delivery, Plantapon Amino ASP for gentle cleansing and NeoHelix Regenerate for skin regeneration and healthy aging. The launch strengthens BASFY's beauty care solutions portfolio and reinforces its commitment to addressing evolving consumer needs in the growing Asia-Pacific market.
Shares of BASFY have gained 19.6% over the past year compared with the 9.4% rise in its industry.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Avino Silver & Gold Mines Ltd. (ASM - Free Report) and Avient Corporation (AVNT - Free Report) .
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $23.70 per share, indicating a 66.2% year-over-year surge. RS shares have gained 56.2% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 28 cents per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 75%.
The Zacks Consensus Estimate for AVNT’s 2026 earnings is pegged at $3.2 per share, indicating a year-over-year rise of 13.48%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%.
View the Zacks #1 Rank List
Image: Bigstock
BASFY Launches Lincare to Improve Post-Laser Skincare
Key Takeaways
BASF SE (BASFY - Free Report) has launched Lincare, a naturally derived active ingredient designed to support post-laser skincare and promote rejuvenation, at in-cosmetics Asia 2026 in Bangkok, Thailand. The launch underscores the company's focus on supporting innovation in its beauty and personal care portfolio to address the growing need for skin-recovery mechanisms while helping enhance visible aesthetic results.
Derived from flaxseed hull oligosaccharides, Lincare supports skin recovery by soothing post-treatment skin, helping epidermal recovery, strengthening the skin barrier and enhancing visible rejuvenation benefits. Clinical testing demonstrated that a formulation containing 1% Lincare helped the skin barrier recover 21% faster following non-ablative fractional laser treatment, enabling recovery approximately 1.2 days earlier than placebo.
The ingredient also delivered up to twice the skin barrier improvement after 14 days. Additionally, it demonstrated improvements in forehead fine lines, crow's feet and nasolabial folds, along with up to 16% higher skin density after 56 days.
Alongside Lincare, BASFY is showcasing several innovations under its "Beyond Beauty: Future Unlocked" theme. These include Tinosorb A2B for advanced sun care, Emulgade Verde PE for active delivery, Plantapon Amino ASP for gentle cleansing and NeoHelix Regenerate for skin regeneration and healthy aging. The launch strengthens BASFY's beauty care solutions portfolio and reinforces its commitment to addressing evolving consumer needs in the growing Asia-Pacific market.
Shares of BASFY have gained 19.6% over the past year compared with the 9.4% rise in its industry.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Avino Silver & Gold Mines Ltd. (ASM - Free Report) and Avient Corporation (AVNT - Free Report) .
RS currently sports a Zacks Rank #1 (Strong Buy), while ASM and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $23.70 per share, indicating a 66.2% year-over-year surge. RS shares have gained 56.2% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 28 cents per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 75%.
The Zacks Consensus Estimate for AVNT’s 2026 earnings is pegged at $3.2 per share, indicating a year-over-year rise of 13.48%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%.